JBC: A shadowy organizational hub in cells
On a cellular level, we are all hanging on by delicate threads. All cells are crisscrossed by a network of strands called microtubules, which act as railroad tracks that move cargo around the cell, as winch cables that separate chromosomes during cell division and as scaffolding components that give a cell its shape.
Because of its essential role in the cell cycle, microtubule assembly is the target of essential anti-cancer chemotherapies (paclitaxel, for example), which stop out-of-control cell division by destabilizing microtubules. Now, researchers have shed light on the role that a large, enigmatic protein plays in assembling microtubules, paving the way for better treatments. The results of the research were published in the Journal of Biological Chemistry.
A large protein coordinates cellular components required for microtubule assembly.Courtesy of James Goldenring, Vanderbilt University
In 1999, James Goldenring’s research team at Vanderbilt University showed that protein kinase A-anchoring protein 350, or AKAP350, is a component of the centrosome, a center of microtubule organization in human cells. The team later showed that microtubules did not form efficiently without AKAP350. But the way in which AKAP350 regulated microtubule formation was difficult to understand, largely because of the technical challenges posed by AKAP350’s heft.
“Since this protein is so huge, it’s very difficult to study it,” said Elena Kolobova, the research scientist in Goldenring’s laboratory who led the new study. “A few years ago, we finally came to develop synthetic constructs of (AKAP350), which allowed us to go to the next level of evaluation and function.”
Using a combination of detailed biochemical analyses and super-resolution microscopy, the team finally was able to gain some understanding of the complex roles that AKAP350 plays in regulating microtubules in cells. AKAP350 formed a physical bridge spanning components of the centrosome. And AKAP350 appeared to recruit multiple proteins involved in building microtubules, coordinating their function in one spot.
“I like to call this thing Deep Space Nine. Everybody comes to hang out at AKAP350,” Goldenring said. “I think we’ve only scratched the surface of the structural organization that this protein is probably providing.”
Mutations in AKAP350 have been associated with cardiac arrhythmias, so it will be of interest to see whether the protein’s role in microtubule assembly contributes to proper heart function as well.
“I think (AKAP350) is a fundamental regulator of cell function,” Goldenring said. “So we need to know a lot more about this protein before we can even begin looking at what it might mean for disease.”
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Spider-like proteins spin defenses to control immunity
Researchers from Utrecht University discovered two distinct binding modes of a spider-shaped immune inhibitor found in serum.

A biological camera: How AI is transforming retinal imaging
AI is helping clinicians see a more detailed view into the eye, allowing them to detect diabetic retinopathy earlier and expand access through tele-ophthalmology. These advances could help millions see a clearer future.

AI in the lab: The power of smarter questions
An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.

Training AI to uncover novel antimicrobials
Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.

AI-designed biomarker improves malaria diagnostics
Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.

Matrix metalloproteinase inhibitor reduces cancer invasion
Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.